Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao, X Wu… - OncoTargets and …, 2017 - Taylor & Francis
Background Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …
被引用次数：9 相关文章

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao, X Wu… - OncoTargets and …, 2017 - dovepress.com
Background: Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …
[HTML] nih.gov

[HTML][HTML] Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer …

S Sun, H Yu, H Wang, X Zhao, X Zhao, X Wu… - OncoTargets and …, 2017 - ncbi.nlm.nih.gov
Background Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao… - OncoTargets and …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao, X Wu… - OncoTargets and …, 2017 - go.gale.com
Background: Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …

[引用][C] Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer …

S Sun, H Yu, H Wang, X Zhao, X Zhao, X Wu… - OncoTargets and …, 2017 - cir.nii.ac.jp
Exploratory cohort study and meta-analysis of <em>BIM</em> deletion polymorphism in
patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with …

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant nonsmall-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao… - OncoTargets & …, 2017 - search.ebscohost.com
Background: Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Zhao… - OncoTargets and …, 2017 - search.proquest.com
Background: Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated …

S Sun, H Yu, H Wang, X Zhao, X Wu, J Qiao… - Oncotargets and …, 2017 - europepmc.org
Background Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …
[PDF] semanticscholar.org

[PDF][PDF] exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer …

X Zhao, X Zhao, X Wu, J Qiao… - OncoTargets and …, 2017 - pdfs.semanticscholar.org
Background: Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor
receptor (EGFR) mutations might develop primary and secondary resistance to tyrosine …